Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization.

Anti-Bacterial Agents / pharmacology Azabicyclo Compounds Carbapenems / pharmacology Ceftazidime / pharmacology Cephalosporins / pharmacology Humans Microbial Sensitivity Tests Pseudomonas Infections / drug therapy Pseudomonas aeruginosa
Pseudomonas aeruginosa carbapenem resistance cefepime ceftazidime pharmacodynamics pharmacokinetics

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
18 10 2021
Historique:
pubmed: 17 8 2021
medline: 3 11 2021
entrez: 16 8 2021
Statut: ppublish

Résumé

The present study evaluated the

Identifiants

DOI: 10.1128/AAC.01204-21 PMID: 34398670 PMC: PMC8522773
pubmed: 34398670
doi: 10.1128/AAC.01204-21
pmc: PMC8522773
doi:

Substances chimiques

Anti-Bacterial Agents 0
Azabicyclo Compounds 0
Carbapenems 0
Cephalosporins 0
Ceftazidime 9M416Z9QNR

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0120421

Références

Antimicrob Agents Chemother. 2003 Jun;47(6):1853-61
pubmed: 12760858
J Antimicrob Chemother. 1997 Aug;40(2):269-73
pubmed: 9301994
Antimicrob Agents Chemother. 2010 Mar;54(3):1111-6
pubmed: 20038614
J Clin Microbiol. 2021 May 19;59(6):
pubmed: 33441396
J Clin Microbiol. 2015 May;53(5):1712-4
pubmed: 25694527
J Antimicrob Chemother. 2005 May;55(5):601-7
pubmed: 15772142
J Clin Microbiol. 2016 Apr;54(4):840-4
pubmed: 26791363
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1401-10
pubmed: 26666929
Eur J Clin Microbiol Infect Dis. 2021 Jul 22;:
pubmed: 34291323
J Antimicrob Chemother. 2017 May 1;72(5):1421-1428
pubmed: 28158470
Diagn Microbiol Infect Dis. 2007 Feb;57(2):153-61
pubmed: 16930925
Antimicrob Agents Chemother. 2013 Apr;57(4):1730-5
pubmed: 23357773
Clin Infect Dis. 1998 Jan;26(1):1-10; quiz 11-2
pubmed: 9455502
J Clin Microbiol. 2019 Jul 26;57(8):
pubmed: 31118271

Auteurs

Christian M Gill (CM)

Center for Anti-Infective Research & Development, Hartford Hospitalgrid.277313.3, Hartford, Connecticut, USA.

Elif Aktaş (E)

University of Health Sciences, Sisli Hamidiye Etfal Training and Research Hospital, Clinical Microbiology Laboratory, Istanbul, Turkey.

Wadha Alfouzan (W)

Laboratory Medicine, Farwaniya Hospital, Ministry of Health, Kuwait City, Kuwait.
Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.

Lori Bourassa (L)

Department of Laboratory Medicine and Pathology, University of Washingtongrid.34477.33, Seattle, Washington, USA.
ORCID: 0000-0001-8903-5274

Adrian Brink (A)

Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, National Health Laboratory Services, University of Cape Town, Cape Town, South Africa.

Carey-Ann D Burnham (CD)

Washington University in St. Louis, School of Medicine, St. Louis, Missouri, USA.

Rafael Canton (R)

Servicio de Microbiologia, Hospital Ramón y Cajal-IRYCIS, Madrid, Spain.
ORCID: 0000-0003-1675-3173

Yehuda Carmeli (Y)

National Institute for Infection Control and Antibiotic Resistance, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.

Marco Falcone (M)

Infectious Diseases Division, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Carlos Kiffer (C)

Internal Medicine Department and LEMC, Alerta Lab, Escola Paulista de Medicina, UNIFESP, São Paulo, Brazil.

Anna Marchese (A)

Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.
Clinical Microbiology Unit, San Martino Policlinico Hospital-IRCCS for Oncology and Neuroscience, Genoa, Italy.

Octavio Martinez (O)

Department of Pathology and Microbiology, Miller School of Medicine, University of Miami, Miami, Florida, USA.

Spyros Pournaras (S)

Laboratory of Clinical Microbiology, School of Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Harald Seifert (H)

Institute for Medical Microbiology, Immunology and Hygiene, University of Colognegrid.6190.e, Cologne, Germany.

Abrar K Thabit (AK)

Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz Universitygrid.412125.1, Jeddah, Saudi Arabia.
ORCID: 0000-0002-0369-9094

Maria Virginia Villegas (MV)

Grupo de Resistencia Antimicrobiana y Epidemiología Hospitalaria (RAEH), Universidad El Bosque, Bogotá, Colombia.

Lars F Westblade (LF)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.

David P Nicolau (DP)

Center for Anti-Infective Research & Development, Hartford Hospitalgrid.277313.3, Hartford, Connecticut, USA.
Division of Infectious Diseases, Hartford Hospitalgrid.277313.3, Hartford, Connecticut, USA.
ORCID: 0000-0002-4148-0165

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Elevated MICs of Susceptible Antipseudomonal...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques, cycle ponté › Composés hétérocycliques bicycliques › Composés azabicycliques › Elevated MICs of Susceptible Antipseudomonal...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Carbapénèmes › Elevated MICs of Susceptible Antipseudomonal...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Céphalosporines › Céfaloridine › Ceftazidime › Elevated MICs of Susceptible Antipseudomonal...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Céphalosporines › Elevated MICs of Susceptible Antipseudomonal...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Elevated MICs of Susceptible Antipseudomonal...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Elevated MICs of Susceptible Antipseudomonal...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Pseudomonas › Elevated MICs of Susceptible Antipseudomonal...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Pseudomonadaceae › Pseudomonas › Pseudomonas aeruginosa › Elevated MICs of Susceptible Antipseudomonal...